Patrick K Ha

28PUBLICATIONS

146CO-AUTHORS

Predictive and prognostic markersEvolutionary computationMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|Jun 18, 2026

Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With Pembrolizumab.

|Jun 12, 2026

Economic Impact of a Deep Learning Algorithm for Automated Head and Neck Surgery Referral Triage.

|May 25, 2026

Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.

|May 14, 2026

Changes in Time to Diagnosis of HPV<sup>+</sup> Oropharyngeal Squamous Cell Carcinoma.

|May 10, 2026

Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer.

|May 05, 2026

Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinoma.

Pageof 5

Frequent Collaborators

Sue S Yom

Katherine Wai

Mary Jue Xu

Chase M Heaton

Ivan H El-Sayed

Hyunseok Kang

Arushi Gulati

Joseph O Humtsoe

Angeline A Truong

Leilani Jones

Frequent Collaborators

Sue S Yom

Katherine Wai

Mary Jue Xu

Chase M Heaton